Active substance
Betaxolol
- SFDA 3
- US FDA 9
- US price lines 6
- NHS prices 3
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BETOPTIC OPTHALMIC SOLUTION 0.5% | 0.5 % | Ophthalmic solution · Ocular use | 1 Dropper Container | SAR 11.40 | NCE · Prescription | NOVARTIS PHARMA AG | Valid |
| KERLONE TAB F.C. 20MG | 20 mg | Film-coated tablet · Oral use | 28 Blister | SAR 40.15 | NCE · Prescription | sanofi-aventis | Withdrawn by MAH · Not Marketed |
| RIALOL | 0.5 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 29.10 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
OPEN ANGLE GLUCOMA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| BETOPTIC | EQ 0.5% BASE | solution/drops · ophthalmic | SANDOZ | Prescription | 30 Aug 1985 |
| BETOPTIC S | EQ 0.25% BASE | suspension/drops · ophthalmic | NOVARTIS | Prescription | 29 Dec 1989 |
| BETAXOLOL HYDROCHLORIDE | 10MG; 20MG | tablet · oral | EPIC PHARMA | Prescription | 22 Oct 1999 |
| BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | solution/drops · ophthalmic | EUROFARMA | Prescription | 12 Apr 2001 |
| BETAXOLOL HYDROCHLORIDE | 10MG; 20MG | tablet · oral | KVK TECH | Prescription | 27 Jun 2008 |
| BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | solution/drops · ophthalmic | CHARTWELL RX | Prescription | 16 Nov 2009 |
| KERLONE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | SANOFI AVENTIS US | Discontinued | 27 Oct 1989 |
| BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | solution/drops · ophthalmic | PHARMOBEDIENT | Discontinued | 30 Jun 2000 |
| BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | solution/drops · ophthalmic | APOTEX INC | Discontinued | 28 Sep 2000 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | BETAXOLOL 10 MG TABLET | $0.59124 | per EA | 23 Sep 2026 |
| US NADAC | BETAXOLOL 20 MG TABLET | $0.79502 | per EA | 19 Nov 2025 |
| US NADAC | BETAXOLOL HCL 0.5% EYE DROP | $8.96243 | per ML | 23 Sep 2026 |
| US NADAC | BETAXOLOL HCL 0.5% EYE DROP | $8.98694 | per ML | 23 Sep 2026 |
| US NADAC | BETOPTIC S 0.25% EYE DROP | $42.62424 | per ML | 7 Jan 2026 |
| US NADAC | BETOPTIC S 0.25% EYE DROP | $42.87902 | per ML | 7 Jan 2026 |
| NHS Drug Tariff | Betaxolol 0.25% eye drops | £2.66 | 5 ml | 1 Oct 2026 |
| NHS Drug Tariff | Betaxolol 0.25% eye drops 0.25ml unit dose preservative free | £13.77 | 50 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Betaxolol 0.5% eye drops | £1.90 | 5 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 9 Jun 2021 BETOPTIC S — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.